ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
콜레스테롤 바이오센서 시장 규모는 최근 급속히 확대되고 있습니다. 2024년 18억 1,000만 달러로 평가되었고, 2025년에는 20억 3,000만 달러에 달할 것으로 추정되며, CAGR 12.1%로 성장이 전망되고 있습니다. 지난 수년간의 성장은 심혈관 질환의 유병률 상승, 고지혈증 발생률 증가, 예방 의료에 대한 의식 증가, 노인 인구 확대, 의료비 지출 증가, POC(Point of Care) 진단의 보급 확대 등의 요인과 관련이 있습니다.
콜레스테롤 바이오센서 시장 규모는 향후 수년간 급속한 성장이 예상됩니다. 2029년에는 31억 7,000만 달러에 달할 것으로 예측되며, CAGR 11.7%로 성장할 전망입니다. 예측 기간의 성장은 가정용 콜레스테롤 모니터링 수요 증가, 스마트폰 및 웨어러블 디바이스와의 바이오센서 통합의 진전, 질병 조기 발견에 대한 주목 증가, 맞춤형 의료에서 용도 범위의 확대, 진단용 바이오센서 기술에 대한 투자 증가에 의해 견인될 전망입니다. 예측 기간 주요 동향으로는 전기화학적 센싱 플랫폼의 진보, 나노 재료 기반 바이오센서에서의 혁신, 저침습 및 비침습형 콜레스테롤 검출법 개발, 진단 해석을 위한 인공지능 통합, 그리고 휴대형 및 접속형 진단 디바이스의 채용 확대를 들 수 있습니다.
향후 수년간 심혈관 질환의 발생률 상승이 콜레스테롤 바이오센서 시장의 성장을 견인할 것으로 예측됩니다. 심혈관 질환은 관상동맥 질환, 심부전, 뇌졸중 등의 상태를 포함한 심장과 혈관에 영향을 미치는 질환군입니다. 심혈관 질환 증가는 주로 건강에 해로운 식습관과 관련이 있으며, 가공 식품과 지방의 과다 복용은 콜레스테롤 수치를 높이고 심장 관련 위험을 증가시킵니다. 콜레스테롤 바이오센서는 콜레스테롤 수치를 빠르고 정확하게 모니터링함으로써 이러한 질병 관리에 중요한 역할을 하며, 예방 의료 및 치료 계획 개발에 필수적입니다. 진료 현장 및 집에서의 검사를 가능하게 하는 것으로 빈번한 통원의 필요성을 최소화해, 환자의 편리성 및 적극적인 헬스케어의 향상에 기여합니다. 예를 들어, 2024년 10월에 미국 정부기관인 질병관리예방센터(CDC)가 발표한 데이터에 의하면, 2023년에는 약 919,032명이 심혈관 질환에 의해 사망했으며, 전 사망자의 3명에 1명을 차지했습니다. 이와 같이 심혈관 질환의 유병률이 증가하고 있는 것이 콜레스테롤 바이오센서 시장의 성장을 뒷받침하고 있습니다.
의료비 지출 증가는 콜레스테롤 바이오센서 시장의 성장을 지원할 것으로 예측됩니다. 의료비 지출이란, 건강 상태의 유지 및 개선을 목적으로 한 의료 서비스, 치료, 시설, 조사, 공중 위생 시책에 소비되는 총 자금을 가리킵니다. 만성 질환 증가에 따라 장기적이고 고액의 치료가 필요한 경우가 증가하고 있으며, 이것이 의료비 증대의 주요 요인이 되고 있습니다. 의료비 증가는 연구개발 및 기술 혁신에 대한 자금 공급을 촉진하여 보다 고도로 정밀한 진단기기의 개발로 이어집니다. 이를 통해 휴대용 실시간 포인트 오브 케어 대응 바이오센서의 생산을 지원하고 환자의 접근성 및 편의성을 향상시키고 적극적인 심혈관 질환의 헬스케어를 촉진합니다. 예를 들어, 2024년 5월에 영국 정부기관인 국가 통계국이 발표한 바에 따르면, 2023년의 명목 의료 지출은 전년 대비 5.6% 증가해, 2022년에 비해 0.9%의 성장을 나타냈습니다. 그 결과, 의료비 지출 증가가 콜레스테롤 바이오센서 시장의 성장을 견인하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향 및 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석 및 전략 분석 프레임워크
세계의 콜레스테롤 바이오센서 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인 및 억제요인)
최종 이용 산업의 분석
세계의 콜레스테롤 바이오센서 시장 : 성장률 분석
세계의 콜레스테롤 바이오센서 시장 실적 : 규모 및 성장(2019-2024년)
세계의 콜레스테롤 바이오센서 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
세계의 콜레스테롤 바이오센서 : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 콜레스테롤 바이오센서 시장 : 제품 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
전기화학 바이오센서
광학식 바이오센서
압전식 바이오센서
기타 제품 유형
세계의 콜레스테롤 바이오센서 시장 : 용도별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
임상 진단
식품 검사
연구소
기타 용도
세계의 콜레스테롤 바이오센서 시장 : 최종 사용자별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
병원 및 진료소
진단센터
연구소
기타 최종 사용자
세계의 콜레스테롤 생체센서 시장 : 전기화학 바이오센서 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
효소 베이스
비효소 베이스
전계 효과 트랜지스터 베이스
도전율 베이스
세계의 콜레스테롤 바이오센서 시장 : 광학 바이오 센서 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
형광 베이스
표면 플라즈몬 공명 베이스
비색 베이스
광섬유 베이스
세계의 콜레스테롤 바이오센서 시장 : 압전식 바이오 센서 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
수정 진동자 마이크로 밸런스 방식
표면 탄성파 베이스
캔틸레버 방식
세계의 콜레스테롤 바이오센서 시장 : 기타 제품 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
열 베이스
자기 베이스
마이크로유체 베이스
나노 재료 베이스
제7장 지역별 및 국가별 분석
세계의 콜레스테롤 바이오센서 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
세계의 콜레스테롤 바이오센서 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도 및 기업 프로파일
콜레스테롤 바이오센서 시장 : 경쟁 구도
콜레스테롤 바이오센서 시장 : 기업 프로파일
Siemens Healthineers AG : 개요, 제품 및 서비스, 전략 및 재무 분석
Roche Holding AG : 개요, 제품 및 서비스, 전략 및 재무 분석
Thermo Fisher Scientific Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Abbott Laboratories : 개요, 제품 및 서비스, 전략 및 재무 분석
Bio-Rad Laboratories Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Randox Laboratories Ltd.
Nova Biomedical Corporation
SEKISUI Diagnostics
Everlywell Inc.
SD Biosensor Inc.
EKF Diagnostics Holdings plc
ACON Laboratories Inc.
Trinity Biotech plc
PTS Diagnostics LLC
EuroMedix International Inc.
VivaChek Biotech Co. Ltd.
Sensa Core Medical Instrumentation Pvt Ltd
Bioptik Technology Inc.
Joy Goal Medical Technology Co. Ltd.
Lifestream Technologies Inc.
제32장 세계 시장 경쟁 벤치마킹 및 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문 및 전략
콜레스테롤 바이오센서 시장(2029년) : 새로운 기회를 제공하는 국가
콜레스테롤 바이오센서 시장(2029년) : 새로운 기회를 제공하는 부문
콜레스테롤 바이오센서 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
AJY
영문 목차
영문목차
A cholesterol biosensor is an analytical device used to detect and measure cholesterol levels in biological samples, such as blood. It typically utilizes an enzyme like cholesterol oxidase to convert cholesterol into measurable signals, often electrical or optical. This enables rapid, accurate, and point-of-care cholesterol monitoring, supporting the diagnosis and management of cardiovascular diseases.
The primary product types of cholesterol biosensors include electrochemical biosensors, optical biosensors, piezoelectric biosensors, and others. Electrochemical biosensors are devices that measure cholesterol levels by translating the biochemical interaction between cholesterol (or its derivatives) and specific enzymes or recognition elements into an electrical signal. These biosensors are used in clinical diagnostics, food testing, research laboratories, and other applications, and serve end users such as hospitals and clinics, diagnostic centers, research laboratories, and more.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.
The cholesterol biosensor market research report is one of a series of new reports from The Business Research Company that provides cholesterol biosensor market statistics, including cholesterol biosensor industry global market size, regional shares, competitors with a cholesterol biosensor market share, detailed cholesterol biosensor market segments, market trends and opportunities, and any further data you may need to thrive in the cholesterol biosensor industry. This cholesterol biosensor market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The cholesterol biosensor market size has grown rapidly in recent years. It will grow from $1.81 billion in 2024 to $2.03 billion in 2025 at a compound annual growth rate (CAGR) of 12.1%. The growth in the historic period can be linked to the rising prevalence of cardiovascular diseases, increasing incidence of hyperlipidemia, growing awareness of preventive healthcare, an expanding elderly population, rising healthcare expenditure, and increasing adoption of point-of-care diagnostics.
The cholesterol biosensor market size is expected to see rapid growth in the next few years. It will grow to $3.17 billion in 2029 at a compound annual growth rate (CAGR) of 11.7%. The growth in the forecast period can be driven by growing demand for home-based cholesterol monitoring, increasing integration of biosensors with smartphones and wearable devices, rising focus on early disease detection, expanding applications in personalized healthcare, and growing investments in diagnostic biosensor technologies. Major trends in the forecast period include advancements in electrochemical sensing platforms, innovations in nanomaterial-based biosensors, development of minimally invasive and non-invasive cholesterol detection methods, integration of artificial intelligence for diagnostic interpretation, and increasing adoption of portable and connected diagnostic devices.
The rising incidence of cardiovascular diseases is expected to drive the growth of the cholesterol biosensor market in the coming years. Cardiovascular diseases are a group of disorders affecting the heart and blood vessels, including conditions such as coronary artery disease, heart failure, and stroke. The increase in cardiovascular diseases is largely linked to unhealthy dietary habits, where excessive consumption of processed foods and fats raises cholesterol levels and increases heart-related risks. Cholesterol biosensors play a critical role in managing these conditions by providing rapid and accurate monitoring of cholesterol levels, making them essential for preventive care and treatment planning. They minimize the need for frequent hospital visits by enabling point-of-care or at-home testing, thereby improving patient convenience and proactive health management. For example, in October 2024, the Centers for Disease Control, a U.S.-based government agency, reported that in 2023 approximately 919,032 people died from cardiovascular disease, accounting for one in every three deaths. This rising prevalence of cardiovascular conditions is therefore fueling the growth of the cholesterol biosensor market.
Increasing healthcare expenditure is expected to support the growth of the cholesterol biosensor market. Healthcare expenditure encompasses the total funds spent on medical services, treatments, facilities, research, and public health initiatives aimed at maintaining or improving health outcomes. The demand for higher healthcare spending is driven by the growing prevalence of chronic diseases, which require long-term and costly treatments. Increased healthcare expenditure facilitates the development of cholesterol biosensors by providing more funding for research and innovation, leading to more advanced and accurate diagnostic devices. This supports the production of portable, real-time, and point-of-care biosensors, enhancing accessibility and convenience for patients while promoting proactive cardiovascular health management. For instance, in May 2024, the Office for National Statistics, a U.K.-based government department, reported a 5.6% increase in nominal healthcare expenditure in 2023, representing a 0.9% growth compared to 2022. Consequently, rising healthcare spending is driving the market growth for cholesterol biosensors.
Leading companies in the cholesterol biosensor market are increasingly developing advanced technologies, such as real-time metabolite mapping systems, to enhance diagnostic capabilities, improve understanding of disease mechanisms, and identify new therapeutic targets. Real-time metabolite mapping allows scientists to dynamically track and visualize the concentration and location of specific molecules within living cells. For example, in November 2023, Nanyang Technological University (NTU), a Singapore-based research university, introduced the GRAM-W Biosensor, a novel cholesterol biosensor capable of tracking cholesterol in live cells in real time at unprecedented resolution. This genetically encoded biosensor enables live-cell imaging of cholesterol distribution and dynamics, incorporating a specific cholesterol-binding domain that fluoresces with intensity proportional to cholesterol concentration, allowing direct observation of cholesterol movement and storage within cellular structures without cell fixation or disruption.
Major companies operating in the cholesterol biosensor market are Siemens Healthineers AG, Roche Holding AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Bio-Rad Laboratories Inc., Randox Laboratories Ltd., Nova Biomedical Corporation, SEKISUI Diagnostics, Everlywell Inc., SD Biosensor Inc., EKF Diagnostics Holdings plc, ACON Laboratories Inc., Trinity Biotech plc, PTS Diagnostics LLC, EuroMedix International Inc., VivaChek Biotech Co. Ltd., Sensa Core Medical Instrumentation Pvt Ltd, Bioptik Technology Inc., Joy Goal Medical Technology Co. Ltd., Lifestream Technologies Inc.
North America was the largest region in the cholesterol biosensor market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in cholesterol biosensor report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the cholesterol biosensor market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The cholesterol biosensor market consists of sales of cardiocheck plus analyzer, accutrend plus system, cholesterol oxidase-based microelectrode sensor, piezoelectric quartz crystal cholesterol sensor, point-of-care testing kits, lab-on-a-chip biosensors, and disposable test strips. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cholesterol Biosensor Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on cholesterol biosensor market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for cholesterol biosensor ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cholesterol biosensor market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product Type: Electrochemical Biosensors; Optical Biosensors; Piezoelectric Biosensors; Other Product Types
2) By Application: Clinical Diagnostics; Food Testing; Research Laboratories; Other Applications
3) By End-User: Hospitals And Clinics; Diagnostic Centers; Research Laboratories; Other End Users
Subsegments:
1) By Electrochemical Biosensors: Enzyme Based; Non Enzyme Based; Field Effect Transistor Based; Conductometric Based
2) By Optical Biosensor: Fluorescence Based; Surface Plasmon Resonance Based; Colorimetric Based; Fiber Optic Based
4) By Other Product Types: Thermal-Based; Magnetic-Based; Microfluidic-Based; Nanomaterial-Based
Companies Mentioned: Siemens Healthineers AG; Roche Holding AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Bio-Rad Laboratories Inc.; Randox Laboratories Ltd.; Nova Biomedical Corporation; SEKISUI Diagnostics; Everlywell Inc.; SD Biosensor Inc.; EKF Diagnostics Holdings plc; ACON Laboratories Inc.; Trinity Biotech plc; PTS Diagnostics LLC; EuroMedix International Inc.; VivaChek Biotech Co. Ltd.; Sensa Core Medical Instrumentation Pvt Ltd; Bioptik Technology Inc.; Joy Goal Medical Technology Co. Ltd.; Lifestream Technologies Inc.
Countries:
Table of Contents
1. Executive Summary
2. Cholesterol Biosensor Market Characteristics
3. Cholesterol Biosensor Market Trends And Strategies
4. Cholesterol Biosensor Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Cholesterol Biosensor Growth Analysis And Strategic Analysis Framework
5.1. Global Cholesterol Biosensor PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Cholesterol Biosensor Market Growth Rate Analysis
5.4. Global Cholesterol Biosensor Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Cholesterol Biosensor Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Cholesterol Biosensor Total Addressable Market (TAM)
6. Cholesterol Biosensor Market Segmentation
6.1. Global Cholesterol Biosensor Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Electrochemical Biosensors
Optical Biosensors
Piezoelectric Biosensors
Other Product Types
6.2. Global Cholesterol Biosensor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Clinical Diagnostics
Food Testing
Research Laboratories
Other Applications
6.3. Global Cholesterol Biosensor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Clinics
Diagnostic Centers
Research Laboratories
Other End Users
6.4. Global Cholesterol Biosensor Market, Sub-Segmentation Of Electrochemical Biosensors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Enzyme Based
Non Enzyme Based
Field Effect Transistor Based
Conductometric Based
6.5. Global Cholesterol Biosensor Market, Sub-Segmentation Of Optical Biosensors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Fluorescence Based
Surface Plasmon Resonance Based
Colorimetric Based
Fiber Optic Based
6.6. Global Cholesterol Biosensor Market, Sub-Segmentation Of Piezoelectric Biosensors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Quartz Crystal Microbalance Based
Surface Acoustic Wave Based
Cantilever Based
6.7. Global Cholesterol Biosensor Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Thermal Based
Magnetic Based
Microfluidic Based
Nanomaterial Based
7. Cholesterol Biosensor Market Regional And Country Analysis
7.1. Global Cholesterol Biosensor Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Cholesterol Biosensor Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
